Gingko biloba extract improves the lipid profile, inflammatory markers, leptin level and the antioxidant status of T2DM patients poorly responding to metformin: A double- blind, randomized, placebo-controlled trial

Gingko biloba extract improves the lipid profile, inflammatory markers, leptin level and the antioxidant status of T2DM patients poorly responding to metformin: A double- blind, randomized, placebo-controlled trial

Abstract The present study aims to evaluate the effects of Ginkgo biloba (GKB) extract as “add- on” therapy with metformin on the lipid profile, inflammatory markers, leptin and the total antioxidant capacity (TAOC) of patients with type 2 diabetes mellitus (T2DM). It is a multi- center, randomized,...

Full description

Bibliographic Details
Main Authors: Saad Abdulrahman Hussain, Tavga Ahmed Aziz, Taha Othman Mahwi, Zheen Aorahman Ahmed
Format: Article
Language:English
Published: Universidade de São Paulo 2022-07-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Ginkgo biloba
Uncontrolled T2DM
Inflammatory markers
Leptin
Antioxidant status
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100612&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100612&tlng=en

Similar Items